Tapewire

Nasdaq · USD

NKTR

NEKTAR THERAPEUTICS

Export transactions ↓
Tapewire entity
4364
SEC CIK
0000906709
Parsed reports
471

Last 12 months

Inside the activity.

0 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202500
Jan 202601
Feb 202602
Mar 202600
Apr 202600
May 202602
Jun 202606
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 23, 2026 Filed Sep 26, 2026 00:29 UTC GrantStock Option · Derivative 4,000 $0.00 Strike: $57.66 $0.00
Disclosure

SEC source: 0001193125-26-403105 · ownership.xml · derivative · entry 4

WHITFIELD ROY A · CIK 0000936728 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2034-09-22

F4 · derivative.exercise_date: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 23, 2026.

Read SEC document
September 23, 2026 Filed Sep 26, 2026 00:29 UTC GrantCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-403105 · ownership.xml · nonDerivative · entry 1

WHITFIELD ROY A · CIK 0000936728 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,417

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This RSU award vests in full, one year following September 23, 2026.

F3 · balance_after: On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.

Read SEC document
September 23, 2026 Filed Sep 26, 2026 00:26 UTC GrantStock Option · Derivative 4,000 $0.00 Strike: $57.66 $0.00
Disclosure

SEC source: 0001193125-26-403103 · ownership.xml · derivative · entry 2

GREER R SCOTT · CIK 0001211703 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2034-09-22

F4 · derivative.exercise_date: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 23, 2026.

Read SEC document
September 23, 2026 Filed Sep 26, 2026 00:26 UTC GrantCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-403103 · ownership.xml · nonDerivative · entry 1

GREER R SCOTT · CIK 0001211703 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,239

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This RSU award vests in full, one year following September 23, 2026.

F3 · balance_after: On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.

Read SEC document
September 23, 2026 Filed Sep 26, 2026 00:22 UTC
CHESS ROBERTDirector
GrantStock Option · Derivative 4,000 $0.00 Strike: $57.66 $0.00
Disclosure

SEC source: 0001193125-26-403101 · ownership.xml · derivative · entry 5

CHESS ROBERT · CIK 0001227886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2034-09-22

F5 · derivative.exercise_date: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 23, 2026.

Read SEC document
September 23, 2026 Filed Sep 26, 2026 00:22 UTC
CHESS ROBERTDirector
GrantCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-403101 · ownership.xml · nonDerivative · entry 1

CHESS ROBERT · CIK 0001227886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,019

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This RSU award vests in full, one year following September 23, 2026.

F3 · balance_after: On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.

Read SEC document
September 23, 2026 Filed Sep 26, 2026 00:20 UTC GrantStock Option · Derivative 4,000 $0.00 Strike: $57.66 $0.00
Disclosure

SEC source: 0001193125-26-403099 · ownership.xml · derivative · entry 2

Brainard Diana · CIK 0001818070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2034-09-22

F4 · derivative.exercise_date: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 23, 2026.

Read SEC document
September 23, 2026 Filed Sep 26, 2026 00:20 UTC GrantCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-403099 · ownership.xml · nonDerivative · entry 1

Brainard Diana · CIK 0001818070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,904

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This RSU award vests in full, one year following September 23, 2026.

F3 · balance_after: On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.

Read SEC document
September 23, 2026 Filed Sep 26, 2026 00:18 UTC GrantStock Option · Derivative 4,000 $0.00 Strike: $57.66 $0.00
Disclosure

SEC source: 0001193125-26-403097 · ownership.xml · derivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2034-09-22

F4 · derivative.exercise_date: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 23, 2026.

Read SEC document
September 23, 2026 Filed Sep 26, 2026 00:18 UTC GrantCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-403097 · ownership.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,277

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2 · deemedExecutionDate: This RSU award vests in full, one year following September 23, 2026.

F3 · balance_after: On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.

Read SEC document
August 18, 2026 Filed Aug 20, 2026 23:05 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 186 $71.98 $13,388.28
Disclosure

SEC source: 0001193125-26-359588 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,570

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $71.78 to $72.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
August 18, 2026 Filed Aug 20, 2026 23:03 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 418 $71.98 $30,087.64
Disclosure

SEC source: 0001193125-26-359586 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,627

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $71.78 to $72.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
July 24, 2026 Filed Jul 24, 2026 22:35 UTC
Zalevsky JonathanChief R&D Officer
GrantStock Option · Derivative 16,500 $0.00 Strike: $15.15 $0.00
Disclosure

SEC source: 0001193125-26-316458 · ownership.xml · derivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2032-12-12

F1 · security: These stock options were granted on December 13, 2024 under the 2017 Amended and Restated Performance Incentive Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of five years from the date of grant.

F2 · derivative.exercise_date: The Organization and Compensation Committee of the Board of Directors of the Issuer determined on July 23, 2026 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on July 24, 2026 (subject to remaining time-based vesting requirements).

Read SEC document
July 24, 2026 Filed Jul 24, 2026 22:34 UTC
ROBIN HOWARD WDirector · President & CEO
GrantStock Option · Derivative 57,200 $0.00 Strike: $15.15 $0.00
Disclosure

SEC source: 0001193125-26-316457 · ownership.xml · derivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,200

Underlying: Common Stock · 57,200 shares

Expires 2032-12-12

F1 · security: These stock options were granted on December 13, 2024 under the 2017 Amended and Restated Performance Incentive Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of five years from the date of grant.

F2 · derivative.exercise_date: The Organization and Compensation Committee of the Board of Directors of the Issuer determined on July 23, 2026 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on July 24, 2026 (subject to remaining time-based vesting requirements).

Read SEC document
June 30, 2026 Filed Jul 2, 2026 23:06 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 5,681 $70.00 $397,670.00
Disclosure

SEC source: 0001193125-26-295112 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,756

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.

Read SEC document
June 17, 2026 Filed Jun 18, 2026 23:08 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 4,500 $61.65 $277,425.00
Disclosure

SEC source: 0001193125-26-276236 · ownership.xml · nonDerivative · entry 4

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,045

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.

F5 · price: This transaction was executed in multiple trades at prices ranging from $61.22 to $62.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
June 17, 2026 Filed Jun 18, 2026 23:08 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 5,500 $60.81 $334,455.00
Disclosure

SEC source: 0001193125-26-276236 · ownership.xml · nonDerivative · entry 3

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,545

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.

F4 · price: This transaction was executed in multiple trades at prices ranging from $60.22 to $61.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 23:08 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 4,697 $60.71 $285,154.87
Disclosure

SEC source: 0001193125-26-276236 · ownership.xml · nonDerivative · entry 2

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,045

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.

F3 · price: This transaction was executed in multiple trades at prices ranging from $60.37 to $61.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 23:08 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 5,303 $59.97 $318,020.91
Disclosure

SEC source: 0001193125-26-276236 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 69,742

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $59.35 to $60.33 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 23:12 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 5,538 $60.71 $336,211.98
Disclosure

SEC source: 0001193125-26-274534 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,437

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $60.06 to $61.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
May 19, 2026 Filed May 21, 2026 22:26 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 199 $65.51 $13,036.49
Disclosure

SEC source: 0001193125-26-235030 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,975

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $64.88 to $68.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
May 19, 2026 Filed May 21, 2026 22:26 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 444 $65.51 $29,086.44
Disclosure

SEC source: 0001193125-26-235027 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,045

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $64.88 to $68.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
February 18, 2026 Filed Feb 21, 2026 00:10 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 180 $73.00 $13,140.00
Disclosure

SEC source: 0001193125-26-061886 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,174

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $72.51 to $74.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
February 18, 2026 Filed Feb 21, 2026 00:10 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 423 $73.00 $30,879.00
Disclosure

SEC source: 0001193125-26-061885 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,489

F1 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $72.51 to $74.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
January 20, 2026 Filed Jan 23, 2026 00:31 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 3,867 $35.67 $137,935.89
Disclosure

SEC source: 0001193125-26-019843 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,354

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.17 to $36.23 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
December 22, 2025 Filed Dec 23, 2025 23:01 UTC
Zalevsky JonathanChief R&D Officer
GrantStock Option · Derivative 25,000 $0.00 Strike: $43.48 $0.00
Disclosure

SEC source: 0001193125-25-331189 · ownership.xml · derivative · entry 2

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-12-21

F2 · derivative.exercise_date: Stock options vest over four years from the date of grant, (December 22, 2025) in substantially equal monthly installments based on continued service.

Read SEC document
December 22, 2025 Filed Dec 23, 2025 23:01 UTC
Zalevsky JonathanChief R&D Officer
GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-331189 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,221

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs vest over four years from the date of grant (December 22, 2025) in substantially equal quarterly installments based on continued service.

Read SEC document
December 22, 2025 Filed Dec 23, 2025 23:01 UTC
ROBIN HOWARD WDirector · President & CEO
GrantStock Option · Derivative 86,667 $0.00 Strike: $43.48 $0.00
Disclosure

SEC source: 0001193125-25-331187 · ownership.xml · derivative · entry 3

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,667

Underlying: Common Stock · 86,667 shares

Expires 2033-12-21

F2 · derivative.exercise_date: Stock options vest over four years from the date of grant, (December 22, 2025) in substantially equal monthly installments based on continued service.

Read SEC document
December 22, 2025 Filed Dec 23, 2025 23:01 UTC
ROBIN HOWARD WDirector · President & CEO
GrantCommon Stock 21,667 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-331187 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,912

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs vest over four years from the date of grant (December 22, 2025) in substaintially equal quarterly installments based on continued service.

Read SEC document
November 25, 2025 Filed Nov 26, 2025 01:30 UTC
Zalevsky JonathanChief R&D Officer
SaleCommon Stock 1,157 $54.28 $62,801.96
Disclosure

SEC source: 0001193125-25-297855 · ownership.xml · nonDerivative · entry 2

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,971

F3 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $58.26 to $59.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
November 25, 2025 Filed Nov 26, 2025 01:29 UTC
Wilson Mark AndrewChief Legal Officer
SaleCommon Stock 630 $54.28 $34,196.40
Disclosure

SEC source: 0001193125-25-297852 · ownership.xml · nonDerivative · entry 2

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,585

F4 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F5 · price: This transaction was executed in multiple trades at prices ranging from $58.26 to $59.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

F3 · balance_after: This number includes 508 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).

Read SEC document
November 25, 2025 Filed Nov 26, 2025 01:28 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 2,207 $54.28 $119,795.96
Disclosure

SEC source: 0001193125-25-297850 · ownership.xml · nonDerivative · entry 2

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,245

F3 · shares: Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $58.26 to $59.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
November 21, 2025 Filed Nov 26, 2025 01:30 UTC
Zalevsky JonathanChief R&D Officer
GrantStock Option · Derivative 4,766 $0.00 Strike: $281.25 $0.00
Disclosure

SEC source: 0001193125-25-297855 · ownership.xml · derivative · entry 3

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,766

Underlying: Common Stock · 4,766 shares

Expires 2028-12-17

F5 · security: These stock options were granted on December 18, 2020 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of four years from the date of grant.

F6 · derivative.exercise_date: The Compensation Committee determined on November 20, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on November 21, 2025.

Read SEC document
November 21, 2025 Filed Nov 26, 2025 01:30 UTC
Zalevsky JonathanChief R&D Officer
GrantCommon Stock 2,666 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-297855 · ownership.xml · nonDerivative · entry 1

Zalevsky Jonathan · CIK 0001789857 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,128

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted on December 18, 2020 under the Issuer's Amended and Restated 2017 Performance Incentive Plan (the "2017 Plan") and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a quarterly pro-rata basis over a period of three years from the date of grant.

F2 · date: The Organization and Compensation Committee of the Board of Directors of the Issuer ("Compensation Committee") determined on November 20, 2025 that the performance-based vesting requirement for these RSUs was satisfied and these RSUs vested on November 21, 2025.

Read SEC document
November 21, 2025 Filed Nov 26, 2025 01:29 UTC
Wilson Mark AndrewChief Legal Officer
GrantStock Option · Derivative 3,400 $0.00 Strike: $281.25 $0.00
Disclosure

SEC source: 0001193125-25-297852 · ownership.xml · derivative · entry 3

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,400

Underlying: Common Stock · 3,400 shares

Expires 2028-12-17

F6 · security: These stock options were granted on December 18, 2020 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of four years from the date of grant.

F7 · derivative.exercise_date: The Compensation Committee determined on November 20, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on November 21, 2025.

Read SEC document
November 21, 2025 Filed Nov 26, 2025 01:29 UTC
Wilson Mark AndrewChief Legal Officer
GrantCommon Stock 1,903 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-297852 · ownership.xml · nonDerivative · entry 1

Wilson Mark Andrew · CIK 0001808356 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,215

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted on December 18, 2020 under the Issuer's Amended and Restated 2017 Performance Incentive Plan (the "2017 Plan") and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a quarterly pro-rata basis over a period of three years from the date of grant.

F2 · date: The Organization and Compensation Committee of the Board of Directors of the Issuer ("Compensation Committee") determined on November 20, 2025 that the performance-based vesting requirement for these RSUs was satisfied and these RSUs vested on November 21, 2025.

F3 · balance_after: This number includes 508 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).

Read SEC document
November 21, 2025 Filed Nov 26, 2025 01:28 UTC
ROBIN HOWARD WDirector · President & CEO
GrantStock Option · Derivative 12,170 $0.00 Strike: $281.25 $0.00
Disclosure

SEC source: 0001193125-25-297850 · ownership.xml · derivative · entry 4

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,170

Underlying: Common Stock · 12,170 shares

Expires 2028-12-17

F5 · security: These stock options were granted on December 18, 2020 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of four years from the date of grant.

F6 · derivative.exercise_date: The Compensation Committee determined on November 20, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on November 21, 2025.

Read SEC document
November 21, 2025 Filed Nov 26, 2025 01:28 UTC
ROBIN HOWARD WDirector · President & CEO
GrantCommon Stock 7,110 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-297850 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,452

F1 · security: Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted on December 18, 2020 under the Issuer's Amended and Restated 2017 Performance Incentive Plan (the "2017 Plan") and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a quarterly pro-rata basis over a period of three years from the date of grant.

F2 · date: The Organization and Compensation Committee of the Board of Directors of the Issuer ("Compensation Committee") determined on November 20, 2025 that the performance-based vesting requirement for these RSUs was satisfied and these RSUs vested on November 21, 2025.

Read SEC document
September 30, 2025 Filed Oct 1, 2025 23:51 UTC GrantStock Option · Derivative 8,000 $0.00 Strike: $56.90 $0.00
Disclosure

SEC source: 0001193125-25-227236 · ownership.xml · derivative · entry 1

GREER R SCOTT · CIK 0001211703 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2033-09-29

F1 · derivative.exercise_date: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025.

Read SEC document
September 30, 2025 Filed Oct 1, 2025 23:52 UTC GrantStock Option · Derivative 8,000 $0.00 Strike: $56.90 $0.00
Disclosure

SEC source: 0001193125-25-227237 · ownership.xml · derivative · entry 1

WHITFIELD ROY A · CIK 0000936728 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2033-09-29

F1 · derivative.exercise_date: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025.

Read SEC document
September 30, 2025 Filed Oct 1, 2025 23:50 UTC GrantStock Option · Derivative 8,000 $0.00 Strike: $56.90 $0.00
Disclosure

SEC source: 0001193125-25-227233 · ownership.xml · derivative · entry 1

Brainard Diana · CIK 0001818070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2033-09-29

F1 · derivative.exercise_date: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025.

Read SEC document
September 30, 2025 Filed Oct 1, 2025 23:51 UTC
CHESS ROBERTDirector
GrantStock Option · Derivative 8,000 $0.00 Strike: $56.90 $0.00
Disclosure

SEC source: 0001193125-25-227235 · ownership.xml · derivative · entry 1

CHESS ROBERT · CIK 0001227886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2033-09-29

F1 · derivative.exercise_date: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025.

Read SEC document
September 30, 2025 Filed Oct 1, 2025 23:49 UTC GrantStock Option · Derivative 8,000 $0.00 Strike: $56.90 $0.00
Disclosure

SEC source: 0001193125-25-227232 · ownership.xml · derivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2033-09-29

F1 · derivative.exercise_date: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025.

Read SEC document
September 09, 2025 Filed Sep 12, 2025 01:01 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 1,210 $48.18 $58,297.80
Disclosure

SEC source: 0000950170-25-114365 · ownership.xml · nonDerivative · entry 4

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,342

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: This transaction was executed in multiple trades at prices ranging from $48.00 to $48.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 09, 2025 Filed Sep 12, 2025 01:01 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 2,156 $47.49 $102,388.44
Disclosure

SEC source: 0000950170-25-114365 · ownership.xml · nonDerivative · entry 3

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,552

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $47.02 to $47.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 09, 2025 Filed Sep 12, 2025 01:01 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 1,200 $46.41 $55,692.00
Disclosure

SEC source: 0000950170-25-114365 · ownership.xml · nonDerivative · entry 2

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,708

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $46.05 to $46.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 09, 2025 Filed Sep 12, 2025 01:01 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 2,100 $45.16 $94,836.00
Disclosure

SEC source: 0000950170-25-114365 · ownership.xml · nonDerivative · entry 1

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,908

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $45.00 to $45.41 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 05, 2025 Filed Sep 9, 2025 00:31 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 1,136 $39.89 $45,315.04
Disclosure

SEC source: 0000950170-25-113691 · ownership.xml · nonDerivative · entry 7

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,008

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F8 · price: This transaction was executed in multiple trades at prices ranging from $39.50 to $40.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 05, 2025 Filed Sep 9, 2025 00:31 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 2,226 $38.82 $86,413.32
Disclosure

SEC source: 0000950170-25-113691 · ownership.xml · nonDerivative · entry 6

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,144

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F7 · price: This transaction was executed in multiple trades at prices ranging from $38.50 to $39.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document
September 05, 2025 Filed Sep 9, 2025 00:31 UTC
ROBIN HOWARD WDirector · President & CEO
SaleCommon Stock 3,304 $37.87 $125,122.48
Disclosure

SEC source: 0000950170-25-113691 · ownership.xml · nonDerivative · entry 5

ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,370

F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · price: This transaction was executed in multiple trades at prices ranging from $37.50 to $38.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.